Pediatrix Medical (MD) Debt to Equity (2016 - 2025)
Pediatrix Medical (MD) has disclosed Debt to Equity for 17 consecutive years, with $0.68 as the latest value for Q3 2025.
- On a quarterly basis, Debt to Equity fell 20.94% to $0.68 in Q3 2025 year-over-year; TTM through Sep 2025 was $0.68, a 20.94% decrease, with the full-year FY2024 number at $0.81, up 8.25% from a year prior.
- Debt to Equity was $0.68 for Q3 2025 at Pediatrix Medical, down from $0.73 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $1.3 in Q1 2021 to a low of $0.06 in Q2 2023.
- A 5-year average of $0.75 and a median of $0.75 in 2022 define the central range for Debt to Equity.
- Peak YoY movement for Debt to Equity: tumbled 92.34% in 2023, then surged 1403.74% in 2024.
- Pediatrix Medical's Debt to Equity stood at $1.12 in 2021, then crashed by 35.21% to $0.73 in 2022, then grew by 2.75% to $0.75 in 2023, then increased by 8.25% to $0.81 in 2024, then fell by 16.22% to $0.68 in 2025.
- Per Business Quant, the three most recent readings for MD's Debt to Equity are $0.68 (Q3 2025), $0.73 (Q2 2025), and $0.78 (Q1 2025).